Egefjord, Lærke
Aarhus University · Aarhus University Hospital
3 papers on CoChat
Most cited papers
- Verified
In Alzheimer’s Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial
Gejl, M., Gjedde, A., Egefjord, L., Møller, A., Hansen, S. B., Vang, K., Rodell, A., Brændgaard, H., Gottrup, H., Schacht, A., et al. (2016) · Frontiers in Aging Neuroscience
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 480
- Verified
Blood-Brain Glucose Transfer in Alzheimer’s disease: Effect of GLP-1 Analog Treatment
Gejl, M., Brock, B., Egefjord, L., Vang, K., Rungby, J., & Gjedde, A. (2017) · Scientific Reports
Alzheimer's disease research and treatmentsBarrier Structure and Function Studies
Cited by 163
- Verified
Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's disease
Nielsen, R. B., Egefjord, L., Angleys, H., Mouridsen, K., Gejl, M., Møller, A., Brock, B., Brændgaard, H., Gottrup, H., Rungby, J., et al. (2017) · Alzheimer's & Dementia
Dementia and Cognitive Impairment ResearchNeurological Disease Mechanisms and Treatments
Cited by 119
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free